CONMED Corporation (CNMD)
NYSE: CNMD · Real-Time Price · USD
58.85
-0.02 (-0.03%)
Mar 31, 2025, 10:11 AM EDT - Market open

CONMED Statistics

Total Valuation

CONMED has a market cap or net worth of $1.82 billion. The enterprise value is $2.74 billion.

Market Cap 1.82B
Enterprise Value 2.74B

Important Dates

The next estimated earnings date is Wednesday, April 23, 2025, after market close.

Earnings Date Apr 23, 2025
Ex-Dividend Date Mar 14, 2025

Share Statistics

CONMED has 30.91 million shares outstanding. The number of shares has decreased by -1.26% in one year.

Current Share Class 30.91M
Shares Outstanding 30.91M
Shares Change (YoY) -1.26%
Shares Change (QoQ) +0.11%
Owned by Insiders (%) 0.80%
Owned by Institutions (%) 116.69%
Float 30.65M

Valuation Ratios

The trailing PE ratio is 13.85 and the forward PE ratio is 13.57. CONMED's PEG ratio is 1.66.

PE Ratio 13.85
Forward PE 13.57
PS Ratio 1.39
Forward PS 1.31
PB Ratio 1.89
P/TBV Ratio n/a
P/FCF Ratio 11.82
P/OCF Ratio 10.89
PEG Ratio 1.66
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.93, with an EV/FCF ratio of 17.82.

EV / Earnings 20.70
EV / Sales 2.10
EV / EBITDA 11.93
EV / EBIT 17.21
EV / FCF 17.82

Financial Position

The company has a current ratio of 2.30, with a Debt / Equity ratio of 0.98.

Current Ratio 2.30
Quick Ratio 0.94
Debt / Equity 0.98
Debt / EBITDA 3.96
Debt / FCF 6.16
Interest Coverage 4.27

Financial Efficiency

Return on equity (ROE) is 14.74% and return on invested capital (ROIC) is 5.33%.

Return on Equity (ROE) 14.74%
Return on Assets (ROA) 4.32%
Return on Invested Capital (ROIC) 5.33%
Return on Capital Employed (ROCE) 7.85%
Revenue Per Employee $335,132
Profits Per Employee $33,955
Employee Count 3,900
Asset Turnover 0.57
Inventory Turnover 1.73

Taxes

In the past 12 months, CONMED has paid $30.61 million in taxes.

Income Tax 30.61M
Effective Tax Rate 18.77%

Stock Price Statistics

The stock price has decreased by -26.57% in the last 52 weeks. The beta is 1.54, so CONMED's price volatility has been higher than the market average.

Beta (5Y) 1.54
52-Week Price Change -26.57%
50-Day Moving Average 63.84
200-Day Moving Average 68.43
Relative Strength Index (RSI) 42.37
Average Volume (20 Days) 488,025

Short Selling Information

The latest short interest is 846,967, so 2.74% of the outstanding shares have been sold short.

Short Interest 846,967
Short Previous Month 1.02M
Short % of Shares Out 2.74%
Short % of Float 2.76%
Short Ratio (days to cover) 5.37

Income Statement

In the last 12 months, CONMED had revenue of $1.31 billion and earned $132.42 million in profits. Earnings per share was $4.25.

Revenue 1.31B
Gross Profit 733.03M
Operating Income 159.28M
Pretax Income 123.90M
Net Income 132.42M
EBITDA 229.74M
EBIT 159.28M
Earnings Per Share (EPS) $4.25
Full Income Statement

Balance Sheet

The company has $24.46 million in cash and $947.16 million in debt, giving a net cash position of -$922.70 million or -$29.85 per share.

Cash & Cash Equivalents 24.46M
Total Debt 947.16M
Net Cash -922.70M
Net Cash Per Share -$29.85
Equity (Book Value) 962.68M
Book Value Per Share 31.15
Working Capital 361.88M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $166.97 million and capital expenditures -$13.08 million, giving a free cash flow of $153.88 million.

Operating Cash Flow 166.97M
Capital Expenditures -13.08M
Free Cash Flow 153.88M
FCF Per Share $4.98
Full Cash Flow Statement

Margins

Gross margin is 56.08%, with operating and profit margins of 12.19% and 10.13%.

Gross Margin 56.08%
Operating Margin 12.19%
Pretax Margin 12.47%
Profit Margin 10.13%
EBITDA Margin 17.58%
EBIT Margin 12.19%
FCF Margin 11.77%

Dividends & Yields

This stock pays an annual dividend of $0.80, which amounts to a dividend yield of 1.36%.

Dividend Per Share $0.80
Dividend Yield 1.36%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 18.82%
Buyback Yield 1.26%
Shareholder Yield 2.62%
Earnings Yield 7.28%
FCF Yield 8.46%
Dividend Details

Analyst Forecast

The average price target for CONMED is $77.20, which is 31.18% higher than the current price. The consensus rating is "Buy".

Price Target $77.20
Price Target Difference 31.18%
Analyst Consensus Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on September 10, 2001. It was a forward split with a ratio of 1.5:1.

Last Split Date Sep 10, 2001
Split Type Forward
Split Ratio 1.5:1

Scores

CONMED has an Altman Z-Score of 2.36 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.36
Piotroski F-Score 8